Feng Competitors

Stocks . Taiwan . 
Stock . Feng Chi Biotech
6744 Stock  TWD 16.45  0.85  4.91%   
Feng Chi Biotech competes with Visgeneer, IXensor, UniPharma, EPS Bio, and Welgene Biotech; as well as few others. The company operates under Healthcare sector and is part of Biotechnology industry. Analyzing Feng Chi competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Feng Chi to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Feng Chi Correlation with its peers.

Feng Chi vs 4170 Correlation

Weak diversification

The correlation between Feng Chi Biotech and 4170 is 0.34 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Feng Chi Biotech and 4170 in the same portfolio, assuming nothing else is changed.

Moving against Feng Stock

  0.457566 Argo Yachts DevelopmentPairCorr
  0.381271 SunWay BiotechPairCorr
Hype
Prediction
LowEstimatedHigh
14.7316.4518.17
Details
Intrinsic
Valuation
LowRealHigh
14.2515.9717.69
Details
Naive
Forecast
LowNextHigh
14.3716.0917.81
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
16.1817.1918.19
Details

Feng Chi Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Feng Chi and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Feng and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Feng Chi Biotech does not affect the price movement of the other competitor.

High positive correlations

4183
+ 0.72
6848
6549
+ 0.72
6621
4197
+ 0.68
6848
4183
+ 0.66
4197
6549
+ 0.55
6848
6662
+ 0.5
4197
  

High negative correlations

7607
- 0.5
6848
4183
- 0.48
7607
7607
- 0.45
4197
4170
- 0.33
4197
6661
- 0.3
7607
4170
- 0.24
4183

Risk-Adjusted Indicators

There is a big difference between Feng Stock performing well and Feng Chi Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Feng Chi's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
6848  1.27 (0.09) 0.00 (1.17) 0.00 
 0.00 
 3.20 
(3.37)
 8.53 
4197  1.41  0.08  0.01 (0.44) 1.83 
(2.42)
 4.35 
(4.23)
 10.00 
6734  4.98  1.21  0.13  4.52  6.91 
(6.65)
 6.36 
(5.44)
 20.89 
6621  1.39  0.10  0.04  0.21  1.80 
(1.63)
 2.81 
(2.54)
 9.14 
7607  1.90 (0.28) 0.00  6.03  0.00 
 0.00 
 3.24 
(4.65)
 14.41 
4183  0.99 (0.24) 0.00 (0.77) 0.00 
 0.00 
 2.56 
(2.35)
 6.53 
6661  0.95 (0.04) 0.00 (0.28) 0.00 
 0.00 
 2.36 
(2.12)
 7.33 
6549  1.41  0.15  0.07  1.59  1.40 
(1.94)
 3.77 
(2.74)
 8.00 
6662  0.89 (0.06) 0.00  0.68  0.00 
 0.00 
 2.14 
(1.72)
 5.46 
4170  2.27  0.00  0.00  0.03  0.00 
 0.00 
 4.44 
(3.81)
 19.83 

Feng Chi Competitive Analysis

The better you understand Feng Chi competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Feng Chi's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Feng Chi's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
6744 6848 4197 6734 6621 7607 4183 6661 6549 6662
 4.91 
 16.45 
Feng
 1.79 
 16.50 
RBC
 2.97 
 10.40 
Visgeneer
 44.59 
 9.89 
IXensor
 5.20 
 12.75 
UniPharma
 2.78 
 17.50 
7607
 0.92 
 16.15 
EPS
 2.56 
 19.05 
Welgene
 1.70 
 8.11 
TaiwanJ
 0.16 
 30.50 
BioLASCO
Market Volatility
(90 Days Market Risk)
Very steady
Not too volatile
Not too volatile
Risky
Not too volatile
Not too volatile
Very steady
Very steady
Not too volatile
Very steady
Market Performance
(90 Days Performance)
Weakest
Weakest
Weakest
Fair
Mild
Weakest
Weakest
Weak
Mild
Weakest
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Unknown
Moderate
High
Low
Unknown
Low
Low
High
Low
Current Valuation
(Equity Enterprise Value)
Fairly Valued
Over Valued
Over Valued
Over Valued
Fairly Valued
Over Valued
Fairly Valued
Fairly Valued
Fairly Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Buy
Strong Hold
Hold
Hold
Strong Buy
Strong Hold
Strong Buy
Buy
Strong Hold
Strong Hold
Current Ratio
4.64
N/A
N/A
4.71
9.6
N/A
2.88
3.89
14.77
7.75
Net Asset
N/A
N/A
427.04 M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Profit Margin
14.19
N/A
0.0251
N/A
-39.93
N/A
9.33
N/A
-237.97
19.91
EBITDA
35.77 M
N/A
19.19 M
(92.19 M)
(15.17 M)
N/A
46.92 M
33.05 M
10.42 M
69.58 M
Operating Margin
15.98
N/A
-0.0208
-696.46
-14.87
N/A
7.56
N/A
-16.9
23.75
Current Valuation
214.9 M
N/A
388.73 M
737.24 M
286.35 M
N/A
345.41 M
N/A
641.12 M
595.07 M
Price To Book
1.66
N/A
1.39
9.15
1.23
N/A
1.36
N/A
4.23
1.68
Beta
N/A
N/A
0.64
0.99
1.18
N/A
1.3
0.33
0.27
0.44
Number Of Employees
31
N/A
13
N/A
42
N/A
121
11
16
79
Shares Outstanding
15.4 M
N/A
30.18 M
49.41 M
35.2 M
N/A
23.8 M
N/A
69.2 M
25.61 M
Cash Flow From Operations
39.28 M
N/A
12.34 M
(70.8 M)
(17.18 M)
N/A
37.37 M
34.62 M
10.53 M
73.88 M
Total Debt
5.26 M
N/A
170 M
3.8 M
16.82 M
N/A
141.01 M
30.42 M
477 K
70.63 M
Return On Equity
11.58
N/A
0.0162
-89.84
-14.19
N/A
14.88
N/A
-58.57
11.09
Z Score
42.6
N/A
1.2
N/A
16.2
N/A
1.2
11.4
N/A
6.6
Return On Asset
6.48
N/A
-0.0043
-52.32
-2.96
N/A
4.42
N/A
-2.5
6.41
Book Value Per Share
14.62
N/A
7.49
1.6
10.77
N/A
12.43
13.6
2.6
18.39
Total Asset
N/A
N/A
427.04 M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt To Equity
0.023
N/A
N/A
0.047
0.044
N/A
47.6
0.095
0.2
0.15
Last Dividend Paid
1.15
N/A
N/A
N/A
N/A
N/A
0.7
1.1
N/A
2.0
Market Capitalization
374.22 M
N/A
372.74 M
723.78 M
464.65 M
N/A
402.22 M
591.92 M
741.16 M
792.69 M
Price To Earning
14.82
N/A
N/A
N/A
N/A
N/A
9.74
24.19
N/A
15.25
Price To Sales
2.09
N/A
2.12
51.55
3.35
N/A
0.9
N/A
12.01
3.06
Net Income
25.39 M
N/A
820 K
(89.69 M)
(55.35 M)
N/A
41.47 M
22.38 M
(146.88 M)
51.55 M
Earnings Per Share
1.64
N/A
0.12
-1.55
-1.57
N/A
1.74
1.05
-2.14
2.03
Shares Owned By Insiders
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
47.69
Revenue
178.91 M
N/A
165.29 M
14.04 M
138.64 M
N/A
444.68 M
N/A
61.72 M
258.98 M
Cash And Equivalents
219.26 M
N/A
N/A
31.28 M
188.09 M
N/A
202.58 M
239.66 M
100.1 M
263.13 M
Cash Per Share
14.24
N/A
N/A
0.6
5.34
N/A
8.51
10.28
1.45
10.27
Gross Profit
85.92 M
N/A
67.27 M
4.5 M
69.32 M
N/A
95.71 M
N/A
N/A
130.29 M
Day Typical Price
16.45
16.55
10.23
11.95
12.9
17.48
16.25
19.2
8.04
30.5
Accumulation Distribution
N/A
0.0209
0.049
0.6
0.0634
0.042
0.0182
0.0281
0.0488
0.0227
Market Facilitation Index
N/A
0.35
0.51
11.05
0.85
0.75
0.3
0.55
0.4
0.7
Daily Balance Of Power
0
(0.86)
0.5882
(0.72)
(0.82)
(0.67)
(0.50)
(0.91)
(0.35)
(0.07)
Period Momentum Indicator
(0.85)
(0.30)
0.3
(7.96)
(0.70)
(0.50)
(0.15)
(0.50)
(0.14)
(0.05)
Rate Of Daily Change
0.95
0.98
1.03
0.55
0.95
0.97
0.99
0.97
0.98
1.0
Day Median Price
16.45
16.58
10.15
12.98
12.98
17.48
16.3
19.27
8.0
30.5
Price Action Indicator
(0.43)
(0.22)
0.41
(7.06)
(0.58)
(0.23)
(0.23)
(0.47)
0.04
(0.03)
Relative Strength Index
N/A
45.31
57.87
56.48
N/A
N/A
39.94
52.71
N/A
47.19
Coefficient Of Variation
(583.58)
(2,510)
2642.75
1072.44
1499.94
(982.36)
(629.24)
(5,123)
1166.31
(2,340)
Mean Deviation
1.16
1.27
1.41
4.98
1.39
1.9
0.9872
0.9545
1.41
0.8862
Jensen Alpha
(0.33)
(0.09)
0.0792
1.21
0.1008
(0.28)
(0.24)
(0.04)
0.1529
(0.06)
Total Risk Alpha
(0.40)
(0.17)
(0.03)
0.5812
0.0261
(0.42)
(0.30)
(0.10)
0.0626
(0.12)
Sortino Ratio
N/A
N/A
0.0124
0.1342
0.0388
N/A
N/A
N/A
0.071
N/A
Downside Variance
N/A
N/A
9.67
77.63
4.93
N/A
N/A
N/A
2.92
N/A
Standard Deviation
1.76
1.82
2.2
13.16
1.97
2.7
1.39
1.35
1.94
1.16
Kurtosis
1.48
0.5593
0.5866
21.83
1.38
1.89
1.6
1.1
0.3425
0.0177
Potential Upside
2.34
3.2
4.35
6.36
2.81
3.24
2.56
2.36
3.77
2.14
Treynor Ratio
(0.77)
(1.17)
(0.44)
4.52
0.2087
6.03
(0.77)
(0.28)
1.59
0.6773
Maximum Drawdown
7.84
8.53
10.0
20.89
9.14
14.41
6.53
7.33
8.0
5.46
Variance
3.11
3.33
4.86
173.15
3.86
7.28
1.92
1.83
3.76
1.34
Market Risk Adjusted Performance
(0.76)
(1.16)
(0.43)
4.53
0.2187
6.04
(0.76)
(0.27)
1.6
0.6873
Risk Adjusted Performance
(0.12)
(0.02)
0.0341
0.0769
0.0545
(0.07)
(0.11)
(0.01)
0.0683
(0.03)
Skewness
(1.08)
(0.07)
(0.11)
3.34
(0.05)
0.5554
0.2472
0.3584
0.5644
0.2271
Semi Deviation
N/A
N/A
1.83
6.91
1.8
N/A
N/A
N/A
1.4
N/A
Information Ratio
(0.20)
(0.06)
0.0174
0.0898
0.0438
(0.12)
(0.19)
(0.05)
0.0626
(0.08)
Value At Risk
(4.39)
(3.37)
(4.23)
(5.44)
(2.54)
(4.65)
(2.35)
(2.12)
(2.74)
(1.72)
Expected Short fall
N/A
N/A
(2.42)
(6.65)
(1.63)
N/A
N/A
N/A
(1.94)
N/A
Downside Deviation
N/A
N/A
3.11
8.81
2.22
N/A
N/A
N/A
1.71
N/A
Semi Variance
N/A
N/A
3.35
47.76
3.22
N/A
N/A
N/A
1.96
N/A

Feng Chi Competition Performance Charts

Five steps to successful analysis of Feng Chi Competition

Feng Chi's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Feng Chi Biotech in relation to its competition. Feng Chi's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Feng Chi in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Feng Chi's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Feng Chi Biotech, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Feng Chi position

In addition to having Feng Chi in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run SRI Sustainable Growth Thematic Idea Now

SRI Sustainable Growth
SRI Sustainable Growth Theme
Socially responsible investments that include companies making a positive, sustainable or social impact and exclude those making a negative impact. The SRI Sustainable Growth theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize SRI Sustainable Growth Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Feng Stock Analysis

When running Feng Chi's price analysis, check to measure Feng Chi's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Feng Chi is operating at the current time. Most of Feng Chi's value examination focuses on studying past and present price action to predict the probability of Feng Chi's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Feng Chi's price. Additionally, you may evaluate how the addition of Feng Chi to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY